
Defense contractor Leidos' shares LDOS.N rise 1.2% to $174.99 premarket
Jefferies upgrades rating to "buy" from "hold", on company's "healthy dose of earnings power"
Cites LDOS' risk removal on Health & Civil segment margins, potential benefit from Department of Defense sales exposure, AI benefits and upside on Defense Systems segment business
Raises PT to $205 from $185, representing a 10.8% upside to the stock's last close
Says improved sentiment on the H2 bidding environment, established program ramps, favorable positioning on U.S. administration's priorities could offset DOGE headwind
Five brokerages rate the stock "strong buy", four "buy" and nine "hold"; their median PT is $180 - LSEG-compiled data
As of last close, stock had risen 20% YTD